GLAXO

Glaxosmithkline Pharmaceuticals Share PriceGlaxoSmithKline Pharmaceuticals

₹1311.00
6.55 (0.5%)
  • Advice
  • Hold
As on 28 May, 2023 | 22:52 BSE: 500660 NSE: GLAXO

Glaxosmithkline Pharmaceuticals Performance

Day Range

  • Low
  • High
1311.00

52 Week Range

  • Low
  • High
1311.00
  • Open Price
  • Previous Close
  • Volume

Start SIP in GlaxoSmithKline Pharmaceuticals

Start SIP

Glaxosmithkline Pharmaceuticals Share Price

  • Over 1 Month 6.24%
  • Over 3 Month -0.11%
  • Over 6 Month -1.7%
  • Over 1 Year -13.24%

Glaxosmithkline Pharmaceuticals Key Statistics

P/E Ratio 36.4
PEG Ratio -0.6
Market Cap Cr 22,209
Price to Book Ratio 12.8
EPS 35.8
Dividend 6.9
Relative Strength Index 62.31
Money Flow Index 62.32
MACD Signal 7.46
Average True Range 21.07

Glaxosmithkline Pharmaceuticals Investment Rating

  • Master Rating:
  • Glaxosmithkline Pharms. has an operating revenue of Rs. 3,251.72 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 26% is great, ROE of 35% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

GlaxoSmithKline Pharmaceuticals Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 782799906729792
Operating Expenses Qtr Cr 615571649582619
Operating Profit Qtr Cr 167228257148173
Depreciation Qtr Cr 1716161615
Interest Qtr Cr 10010
Tax Qtr Cr 56606944262
Net Profit Qtr Cr 1311641941191,218

Glaxosmithkline Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1311.00
6.55 (0.5%)
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹1286.05
  • 50 Day
  • ₹1279.84
  • 100 Day
  • ₹1292.53
  • 200 Day
  • ₹1337.21
  • 20 Day
  • ₹1278.25
  • 50 Day
  • ₹1275.03
  • 100 Day
  • ₹1280.73
  • 200 Day
  • ₹1331.5

Glaxosmithkline Pharmaceuticals Resistance and Support

PIVOT
₹1305.32
Resistance
First Resistance ₹1315.64
Second Resistance ₹1326.82
Third Resistance ₹1337.14
RSI 62.31
MFI 62.32
MACD Single Line 7.46
MACD 11.57
Support
First Resistance ₹1294.14
Second Resistance ₹1283.82
Third Resistance ₹1272.64

Glaxosmithkline Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 17,994 1,215,315 67.54
Week 49,430 4,106,133 83.07
1 Month 70,377 5,333,147 75.78
6 Month 51,694 3,693,516 71.45

Glaxosmithkline Pharmaceuticals Result Highlights

GlaxoSmithKline Pharmaceuticals Synopsis

NSE-Medical-Diversified

Glaxosmithkline Phar is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3216.34 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2023. GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151.
Market Cap 22,175
Sales 3,216
Shares in Float 4.24
No of funds 405
Yield 2.44
Book Value 12.65
U/D Vol ratio 0.7
LTDebt / Equity
Alpha -0.06
Beta 0.02

GlaxoSmithKline Pharmaceuticals

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 75%75%75%75%
Mutual Funds 3.96%4.12%3.82%4.06%
Insurance Companies 6.29%6.1%6.62%
Foreign Portfolio Investors 2.28%2.28%2.17%2.16%
Financial Institutions/ Banks 0.01%0.01%0.01%0.02%
Individual Investors 10.54%10.56%10.4%10.41%
Others 1.92%1.93%1.98%8.35%

GlaxoSmithKline Pharmaceuticals Management

Name Designation
Ms. R S Karnad Chairperson
Mr. Sridhar Venkatesh Managing Director
Dr.(Ms.) S Maheshwari Director
Mr. S Williams Director
Mr. P V Bhide Director
Mr. N Kaviratne Director
Mr. A N Roy Director
Mr. D Sundaram Director
Mr. M Anand Director
Mr. J Chandy Director

Glaxosmithkline Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Glaxosmithkline Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-05-17 Audited Results & Final Dividend
2023-02-07 Quarterly Results
2022-11-11 Quarterly Results
2022-07-25 Quarterly Results
2022-05-16 Audited Results & Dividend
Date Purpose Remarks
2022-07-08 FINAL Rs.30.00 per share(300%)Dividend
2022-07-08 SPECIAL Rs.60.00 per share(600%)Special Dividend
2021-07-20 FINAL Rs.30.00 per share(300%)Dividend

GlaxoSmithKline Pharmaceuticals MF Shareholding

Name Amount(cr)
ICICI Prudential Bluechip Fund Growth 35877
ICICI Prudential Value Discovery Fund Growth 28471
Aditya Birla Sun Life ELSS Tax Relief 96 Pyt of Inc Dis cum Cap Wdrl 13223
SBI Magnum Midcap Fund Regular Growth 9370
ICICI Prudential Large & Mid Cap Fund Growth 7364

GlaxoSmithKline Pharmaceuticals FAQs

What is Share Price of GlaxoSmithKline Pharmaceuticals ?

GlaxoSmithKline Pharmaceuticals share price is ₹1311 As on 28 May, 2023 | 22:38

What is the Market Cap of GlaxoSmithKline Pharmaceuticals ?

The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹22209.1 Cr As on 28 May, 2023 | 22:38

What is the P/E ratio of GlaxoSmithKline Pharmaceuticals ?

The P/E ratio of GlaxoSmithKline Pharmaceuticals is 36.4 As on 28 May, 2023 | 22:38

What is the PB ratio of GlaxoSmithKline Pharmaceuticals ?

The PB ratio of GlaxoSmithKline Pharmaceuticals is 12.8 As on 28 May, 2023 | 22:38

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number